K-V Pharmaceutical Company Receives Notification From New York Stock Exchange Of Compliance With Quantitative Continued Listing Standards
September 02, 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
August 09, 2010
K-V Pharmaceutical Company Engages BDO USA, LLP as Independent Registered Accountants
August 03, 2010
K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance with Continued Listing Standards
August 02, 2010
K-V Pharmaceutical Names Thomas Mchugh Chief Financial Officer
July 15, 2010
K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva
July 13, 2010
K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing Of Its Annual Report On Form 10-K For Fiscal Year 2010
July 08, 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Director
July 07, 2010
K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
June 18, 2010
K-V Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
June 11, 2010
|
|
The Press Releases shown in this section of the Web
site are presented for archival purposes only. The Press Releases are presented as they were
originally released. The Company makes no claim that the information contained in these materials
is currently accurate or is presented in a manner that would be appropriate for dissemination as
a press release at the present time. See
also KV
Pharmaceutical Company Web Site Terms of Use and Legal Restrictions and Product
Disclaimer. |
|